DS-01 Trademark
DS-01 is a USPTO trademark filed by SEED HEALTH, INC.. Status: Registered.
Prosecution Summary
**Trademark Summary** **DS-01** is registered for **pharmaceutical preparations and substances**, including those for enhancing gastrointestinal, cardiovascular, dermatological, immunological, and metabolic health, as well as related medical, therapeutic, or prophylactic uses. It also covers naturopathic and probiotic preparations and substances, dietetic preparations and preparations adapted for medical purposes, dietary supplements, and probiotic/prebiotic formulations (including capsules for increasing strains of beneficial bacteria), along with pharmaceutical preparations for microbiome dysbiosis restoration. The mark is **registered** (registered status; registration date used to determine post-registration maintenance due dates) and has a registration date of **August 9, 2022**. Th
Trademark Facts
| Mark | DS-01 |
|---|---|
| Serial Number | 88807101 |
| Registration Number | 6815589 |
| Status | Registered |
| Filing Date | 2020-02-23 |
| Registration Date | 2022-08-09 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | SEED HEALTH, INC. |
| Attorney of Record | Kristen McCallion |
| Prosecution Events | 41 |
| Latest Event | TCCA on 2025-01-24 |
Goods & Services
Pharmaceutical preparations and substances for enhancing gastrointestinal, cardiovascular, dermatological, immunological, and metabolic health; preparations and substances for medical, therapeutic or prophylactic use for enhancing gastrointestinal, cardiovascular, dermatological, immunological, and metabolic health; naturopathic and probiotic preparations and substances for enhancing gastrointestinal, cardiovascular, dermatological, immunological, and metabolic health; dietetic preparations and preparations adapted for medical purposes; dietary supplements; probiotic and prebiotic formulations, namely, capsules for increasing strains of beneficial bacteria; pharmaceutical preparations for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome